KinetiSol® has been the subject of numerous research articles published in top peer-reviewed journals in recent years. These papers demonstrate unique capabilities of the KinetiSol process and its benefits for amorphous solid dispersion processing. Key advantages of the KinetiSol process are illustrated in these case studies.
WHY USE KINETISOL?
KinetiSol Fits In-Line with Existing Manufacturing Operations
KinetiSol is a new unit operation for pharmaceutical manufacturing; however, the operations upstream and downstream of the KinetiSol compounder are conventional. The amorphous powder intermediate resulting from the KinetiSol process train can be utilized as a powder for constitution, or can be further processed into any conventional oral dosage form.